1. < Home

PCSK9 inhibitors

Coronary artery calcium comes of age: From risk marker to treatment threshold

Mora R, Budoff MJ. Coronary artery calcium comes of age: From risk marker to treatment threshold. J Cardiovasc Comput Tomogr. 2026 Oct 23:S1934-5925(26)00496-X. doi: 10.1016/j.jcct.2026.10.002.[...]

By afschroeder • October 24, 2026
Effect of Omega-3 fatty acids, fibrates and PCSK9 inhibitors on atherosclerotic plaque burden, composition and stability: Insights from imaging

Roman S, Budoff MJ. Effect of Omega-3 fatty acids, fibrates and PCSK9 inhibitors on atherosclerotic plaque burden, composition and stability: Insights from imaging. Pharmacol Ther.[...]

By afschroeder • June 9, 2026
The lipid lowering efficacy of PCSK9 inhibitors alone vs. statins alone: a meta-analysis

Kyan K, Gornbein J, Saver J. The lipid lowering efficacy of PCSK9 inhibitors alone vs. statins alone: a meta-analysis. Front Cardiovasc Med. 2026 Feb 17;13:1769430.[...]

By afschroeder • March 5, 2026